Your ApoB Is High, and Your Genes May Be Why.

APOE codes for apolipoprotein E, a protein your liver uses to grab LDL particles from your bloodstream and pull them back inside for processing. It’s the primary mechanism for clearing LDL. Without functional APOE, particles stay in circulation, oxidize, and deposit in your artery walls.

Your APOE comes in three variants: e2, e3, and e4. The e4 allele, carried by roughly 25% of people with European ancestry, is the problem. If you carry even one e4 copy, your liver clears LDL particles significantly less efficiently than people with e3/e3. That means your ApoB stays elevated even when your diet is perfect.

You feel this as a lipid panel that doesn’t budge despite months of clean eating. Your triglycerides might be fine, your HDL decent, but LDL and ApoB remain stubbornly high. You’re frustrated because you’re following the advice, and your genes aren’t cooperating.

PCSK9 is a regulatory protein that decides whether your liver holds onto LDL receptors or destroys them. More receptors mean more particle clearance. When PCSK9 works normally, it maintains a healthy balance. But certain PCSK9 variants, called gain-of-function mutations, over-activate this destruction pathway.

Gain-of-function PCSK9 variants are carried by roughly 1 to 3% of the population, but they have an outsized effect. If you carry one, your liver destroys LDL receptors faster than it replaces them, leaving you with fewer receptors and dramatically elevated LDL and ApoB. This is one of the most powerful genetic drivers of high cholesterol.

You experience this as LDL that climbs despite statins. You might have been told you’re “statin resistant.” Your ApoB might be in the 150 range or higher even on medication. You’re young, you’re healthy, but your lipids look like a 60-year-old’s. That’s PCSK9 gain-of-function.

LDLR codes for the LDL receptor itself, the physical machinery on your liver cells that grabs LDL particles and pulls them inside. Without functional receptors, particles can’t be cleared no matter how much you exercise. There are over 1,000 known mutations in LDLR, and roughly 1 in 300 people carry one. Together, these cause familial hypercholesterolemia (FH).

If you carry a pathogenic LDLR variant, your liver has 50% fewer LDL receptors than normal, or the receptors don’t function properly, meaning your cells simply cannot clear as many particles as they should. Diet helps a little. Statins help more. But the fundamental problem is hardware limitation, not a processing speed problem.

You experience this as lifelong high cholesterol. Your ApoB has been high since childhood (though you might not have measured it then). Your doctor hints at family history. If you’re a man, your first heart attack risk shoots up after 40. If you’re a woman, it climbs after 50. You’ve never had the luxury of “normal” cholesterol, only degrees of less high.

APOB is the structural protein on the surface of every LDL particle. It’s the handle the LDL receptor grabs to pull particles inside. If APOB is defective, the handle doesn’t work, and particles can’t be cleared even if you have plenty of functional LDL receptors.

Certain APOB variants, like R3527Q, produce a protein that can’t bind the receptor properly. These variants cause familial defective ApoB (FDB) and account for roughly 5% of familial hypercholesterolemia cases. If you carry a pathogenic APOB variant, your LDL particles are structurally unable to attach to receptors, meaning they accumulate in your bloodstream regardless of how many receptors your liver makes.

You experience this as high ApoB that doesn’t respond well to statins or lifestyle changes. Like LDLR mutations, you’ve likely had elevated cholesterol for years. Your particles accumulate and oxidize, increasing atherosclerosis risk. Standard dietary advice helps marginally, but the real problem is the shape of your particles, not the amount you eat.

CETP (cholesteryl ester transfer protein) is a carrier that moves cholesterol from HDL particles (the good ones) into LDL particles (the bad ones), and triglycerides in the opposite direction. It’s a balancing act. When CETP works normally, it maintains a steady flow. Certain variants, like TaqIB and I405V, reduce CETP activity.

Roughly 40% of the population carries CETP variants that slow this transfer. When CETP is less active, cholesterol builds up in HDL (raising it) but can also shift LDL into smaller, denser particles that are more likely to oxidize and penetrate artery walls, raising ApoB and cardiovascular risk despite a higher HDL number. This is why HDL alone is a poor predictor; particle composition matters more.

You experience this as a confusing lipid panel: your HDL looks good, even high, but your ApoB is still elevated. Your doctor says “that’s good,” but you’re still at risk. Your LDL is smaller and more numerous because CETP variants shift particle composition. The good HDL number is masking the dangerous particle situation.

Lipoprotein(a) is a specific type of LDL particle with an additional protein (apo(a)) attached. It’s structurally similar to LDL but genetically determined and largely independent of lifestyle. Roughly 20% of the population has genetically elevated Lp(a). You cannot diet or exercise it away.

If you have high Lp(a) from your LPA gene, your cardiovascular risk is substantially elevated regardless of your other lipids, because Lp(a) particles are more likely to oxidize, to lodge in artery walls, and to trigger inflammation. This is why two people with the same ApoB can have different outcomes. The LPA component adds independent risk.

You experience this as risk that doesn’t match your other numbers. Your total cholesterol might be controlled, your LDL decent, but an astute cardiologist orders an Lp(a) test and finds it’s 80 or 120 or higher. Your family history of early heart attacks suddenly makes sense. You can’t blame diet anymore because you’re already eating well. It’s genetic, and it requires targeted management.